Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1241.10

-4.40 (-0.35%)

< Home < Back

USFDA completes audit at Dr. Reddy's Lab’s Formulations Srikakulam Plant

Date: 17-02-2020

US Food and Drug Administration (USFDA) has completed audit at Dr. Reddy's Laboratories’ Formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh. The audit completed on February 14, 2020 with zero observation.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.